114
Views
62
CrossRef citations to date
0
Altmetric
Original Research

Clinical significance of Fusobacterium nucleatum, epithelial–mesenchymal transition, and cancer stem cell markers in stage III/IV colorectal cancer patients

, , , &
Pages 5031-5046 | Published online: 17 Oct 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Yanxuan Xie, Xiaoyang Jiao, Mi Zeng, Zhiqiang Fan, Xin Li, Yumeng Yuan, Qiaoxin Zhang & Yong Xia. (2022) Clinical Significance of Fusobacterium nucleatum and Microsatellite Instability in Evaluating Colorectal Cancer Prognosis. Cancer Management and Research 14, pages 3021-3036.
Read now
Yongkang Chen, Yong Yang & Jin Gu. (2020) Clinical Implications of the Associations Between Intestinal Microbiome and Colorectal Cancer Progression. Cancer Management and Research 12, pages 4117-4128.
Read now
Shujie Chen, Tingting Su, Ying Zhang, Allen Lee, Jiamin He, Qiwei Ge, Lan Wang, Jianmin Si, Wei Zhuo & Liangjing Wang. (2020) Fusobacterium nucleatum promotes colorectal cancer metastasis by modulating KRT7-AS/KRT7. Gut Microbes 11:3, pages 511-525.
Read now
Khalid El Bairi, Rachid Jabi, Dario Trapani, Hanae Boutallaka, Bouchra Ouled Amar Bencheikh, Mohammed Bouziane, Mariam Amrani, Said Afqir & Adil Maleb. (2020) Can the microbiota predict response to systemic cancer therapy, surgical outcomes, and survival? The answer is in the gut. Expert Review of Clinical Pharmacology 13:4, pages 403-421.
Read now

Articles from other publishers (58)

María Belén Novoa Díaz, Pedro Carriere & Claudia Gentili. (2023) How the interplay among the tumor microenvironment and the gut microbiota influences the stemness of colorectal cancer cells. World Journal of Stem Cells 15:5, pages 281-301.
Crossref
Himani Pandey, Daryl W. T. Tang, Sunny H. Wong & Devi Lal. (2023) Gut Microbiota in Colorectal Cancer: Biological Role and Therapeutic Opportunities. Cancers 15:3, pages 866.
Crossref
Junchuan Li, Yuzhou Zhu, Lie Yang & Ziqiang Wang. (2022) Effect of gut microbiota in the colorectal cancer and potential target therapy. Discover Oncology 13:1.
Crossref
Yi Wang, Yuting Wen, Jiayin Wang, Xin Lai, Ying Xu, Xuanping Zhang, Xiaoyan Zhu, Chenglin Ruan & Yao Huang. (2022) Clinicopathological differences of high Fusobacterium nucleatum levels in colorectal cancer: A review and meta-analysis. Frontiers in Microbiology 13.
Crossref
Real Sumayya Abdul Sattar, Renu Verma, Nimisha, Arun Kumar, Ghulam Mehdi Dar, Apurva, Abhay Kumar Sharma, Indu Kumari, Ejaj Ahmad, Asgar Ali, Bhawna Mahajan & Sundeep Singh Saluja. (2022) Diagnostic and prognostic biomarkers in colorectal cancer and the potential role of exosomes in drug delivery. Cellular Signalling 99, pages 110413.
Crossref
Zihong Wu, Qiong Ma, Ying Guo & Fengming You. (2022) The Role of Fusobacterium nucleatum in Colorectal Cancer Cell Proliferation and Migration. Cancers 14:21, pages 5350.
Crossref
Wen-Dan Chen, Xin Zhang, Meng-Jiao Zhang, Ya-Ping Zhang, Zi-Qi Shang, Yi-Wei Xin & Yi Zhang. (2022) Salivary Fusobacterium nucleatum serves as a potential diagnostic biomarker for gastric cancer . World Journal of Gastroenterology 28:30, pages 4120-4132.
Crossref
Pamela Pignatelli, Federica Maria Romei, Danilo Bondi, Michele Giuliani, Adriano Piattelli & Maria Cristina Curia. (2022) Microbiota and Oral Cancer as A Complex and Dynamic Microenvironment: A Narrative Review from Etiology to Prognosis. International Journal of Molecular Sciences 23:15, pages 8323.
Crossref
Kaibin Chang, Lei Jiang, Yifeng Sun & He Li. (2022) Effect of E-cadherin on Prognosis of Colorectal Cancer: A Meta-Analysis Update. Molecular Diagnosis & Therapy 26:4, pages 397-409.
Crossref
Qianqian Guo, Hai Qin, Xueling Liu, Xinxin Zhang, Zelong Chen, Tingting Qin, Linlin Chang & Wenzhou Zhang. (2022) The Emerging Roles of Human Gut Microbiota in Gastrointestinal Cancer. Frontiers in Immunology 13.
Crossref
Wen-dan Chen, Xin Zhang, Ya-ping Zhang, Cong-bo Yue, Yan-lei Wang, Hong-wei Pan, Yan-li Zhang, Hui Liu & Yi Zhang. (2022) Fusobacterium Nucleatum Is a Risk Factor for Metastatic Colorectal Cancer. Current Medical Science 42:3, pages 538-547.
Crossref
Rui-Xue Huo, Yi-Jia Wang, Shao-Bin Hou, Wei Wang, Chun-Ze Zhang & Xue-Hua Wan. (2022) Gut mucosal microbiota profiles linked to colorectal cancer recurrence. World Journal of Gastroenterology 28:18, pages 1946-1964.
Crossref
Paola Villar-Ortega, Manuela Expósito-Ruiz, Miguel Gutiérrez-Soto, Miguel Ruiz-Cabello Jiménez, José María Navarro-Marí & José Gutiérrez-Fernández. (2022) The association between Fusobacterium nucleatum and cancer colorectal: A systematic review and meta-analysis. Enfermedades infecciosas y microbiologia clinica (English ed.) 40:5, pages 224-234.
Crossref
Paola Villar-Ortega, Manuela Expósito-Ruiz, Miguel Gutiérrez-Soto, Miguel Ruiz-Cabello Jiménez, José María Navarro-Marí & José Gutiérrez-Fernández. (2022) La asociación entre Fusobacterium nucleatum y el cáncer colorrectal: una revisión sistemática y metaanálisis. Enfermedades Infecciosas y Microbiología Clínica 40:5, pages 224-234.
Crossref
Dominik Ternes, Mina Tsenkova, Vitaly Igorevich Pozdeev, Marianne Meyers, Eric Koncina, Sura Atatri, Martine Schmitz, Jessica Karta, Maryse Schmoetten, Almut Heinken, Fabien Rodriguez, Catherine Delbrouck, Anthoula Gaigneaux, Aurelien Ginolhac, Tam Thuy Dan Nguyen, Lea Grandmougin, Audrey Frachet-Bour, Camille Martin-Gallausiaux, Maria Pacheco, Lorie Neuberger-Castillo, Paulo Miranda, Nikolaus Zuegel, Jean-Yves Ferrand, Manon Gantenbein, Thomas Sauter, Daniel Joseph Slade, Ines Thiele, Johannes Meiser, Serge Haan, Paul Wilmes & Elisabeth Letellier. (2022) The gut microbial metabolite formate exacerbates colorectal cancer progression. Nature Metabolism 4:4, pages 458-475.
Crossref
Daichi Nomoto, Yoshifumi Baba, Yang Liu, Hiroyasu Tsutsuki, Kazuo Okadome, Kazuto Harada, Takatsugu Ishimoto, Masaaki Iwatsuki, Shiro Iwagami, Yuji Miyamoto, Naoya Yoshida, Masayuki Watanabe, Toshiro Moroishi, Yoshihiro Komohara, Tomohiro Sawa & Hideo Baba. (2022) Fusobacterium nucleatum promotes esophageal squamous cell carcinoma progression via the NOD1/RIPK2/NF-κB pathway. Cancer Letters 530, pages 59-67.
Crossref
Claire M. Doocey, Karen Finn, Craig Murphy & Caitriona M. Guinane. (2022) The impact of the human microbiome in tumorigenesis, cancer progression, and biotherapeutic development. BMC Microbiology 22:1.
Crossref
Aleksandra Sędzikowska & Leszek Szablewski. (2021) Human Gut Microbiota in Health and Selected Cancers. International Journal of Molecular Sciences 22:24, pages 13440.
Crossref
Emily McIlvanna, Gerard J. Linden, Stephanie G. Craig, Fionnuala T. Lundy & Jacqueline A. James. (2021) Fusobacterium nucleatum and oral cancer: a critical review. BMC Cancer 21:1.
Crossref
Charlotte Henstra, Jasper van Praagh, Peter Olinga & Anika Nagelkerke. (2021) The gastrointestinal microbiota in colorectal cancer cell migration and invasion. Clinical & Experimental Metastasis 38:6, pages 495-510.
Crossref
Dimitra Lamprinaki, Pilar Garcia-Vello, Roberta Marchetti, Charlotte Hellmich, Kelli A. McCord, Kristian M. Bowles, Matthew S. Macauley, Alba Silipo, Cristina De Castro, Paul R. Crocker & Nathalie Juge. (2021) Siglec-7 Mediates Immunomodulation by Colorectal Cancer-Associated Fusobacterium nucleatum ssp. animalis. Frontiers in Immunology 12.
Crossref
Jiangguo Zhang, Zhimo Wang, Hong Lv & Guojun Li. (2021) Identification and Validation of Potential Candidate Genes of Colorectal Cancer in Response to Fusobacterium nucleatum Infection. Frontiers in Genetics 12.
Crossref
Kevin M. Tourelle, Sebastien Boutin, Markus A. Weigand & Felix C. F. Schmitt. (2021) The Association of Gut Microbiota and Complications in Gastrointestinal-Cancer Therapies. Biomedicines 9:10, pages 1305.
Crossref
Wenhua Shao, Natsumi Fujiwara, Yasuhiro Mouri, Satoru Kisoda, Kayo Yoshida, Kaya Yoshida, Hiromichi Yumoto, Kazumi Ozaki, Naozumi Ishimaru & Yasusei Kudo. (2021) Conversion from epithelial to partial-EMT phenotype by Fusobacterium nucleatum infection promotes invasion of oral cancer cells. Scientific Reports 11:1.
Crossref
Liang-Tzung Lin, Yeu-Ching Shi, Chen-Yen Choong & Chen-Jei Tai. (2021) The Fruits of Paris polyphylla Inhibit Colorectal Cancer Cell Migration Induced by Fusobacterium nucleatum-Derived Extracellular Vesicles. Molecules 26:13, pages 4081.
Crossref
Dave E.W. van der Kruijssen, Nelleke P.M. Brouwer, Auke J.S. van der Kuil, Rob H.A. VerhoevenSjoerd G. Elias, Geraldine R. VinkCornelis J.A. Punt, Johannes H.W. de Wilt & Miriam Koopman. (2021) Interaction Between Primary Tumor Resection, Primary Tumor Location, and Survival in Synchronous Metastatic Colorectal Cancer. American Journal of Clinical Oncology 44:7, pages 315-324.
Crossref
Federica Gaiani, Federica Marchesi, Francesca Negri, Luana Greco, Alberto Malesci, Gian Luigi de’Angelis & Luigi Laghi. (2021) Heterogeneity of Colorectal Cancer Progression: Molecular Gas and Brakes. International Journal of Molecular Sciences 22:10, pages 5246.
Crossref
Runqi Zhu, Tianqun Lang, Wenlu Yan, Xiao Zhu, Xin Huang, Qi Yin & Yaping Li. (2021) Gut Microbiota: Influence on Carcinogenesis and Modulation Strategies by Drug Delivery Systems to Improve Cancer Therapy. Advanced Science 8:10.
Crossref
Maryam Ranjbar, Rasoul Salehi, Shaghayegh Haghjooy Javanmard, Laleh Rafiee, Habibollah Faraji, Sima jafarpor, Gordon A. Ferns, Majid Ghayour-Mobarhan, Mostafa Manian & Reza Nedaeinia. (2021) The dysbiosis signature of Fusobacterium nucleatum in colorectal cancer-cause or consequences? A systematic review. Cancer Cell International 21:1.
Crossref
José Guilherme Datorre, Ana Carolina de Carvalho, Denise Peixoto Guimarães & Rui Manuel Reis. (2021) The Role of <b><i>Fusobacterium nucleatum</i></b> in Colorectal Carcinogenesis. Pathobiology 88:2, pages 127-140.
Crossref
George E. Theodoropoulos. 2021. Gut Microbiome-Related Diseases and Therapies. Gut Microbiome-Related Diseases and Therapies 93 168 .
Hal E. Broxmeyer, Yan Liu, Reuben Kapur, Christie M. Orschell, Arafat Aljoufi, James P. Ropa, Thao Trinh, Sarah Burns & Maegan L. Capitano. (2020) Fate of Hematopoiesis During Aging. What Do We Really Know, and What are its Implications?. Stem Cell Reviews and Reports 16:6, pages 1020-1048.
Crossref
Ioannis Koliarakis, Elias Athanasakis, Markos Sgantzos, Theodoros Mariolis-Sapsakos, Evangelos Xynos, Emmanuel Chrysos, John Souglakos & John Tsiaoussis. (2020) Intestinal Microbiota in Colorectal Cancer Surgery. Cancers 12:10, pages 3011.
Crossref
Wenjia Fang, Meilin Ni, Mingming Zhang & Hanqing Chen. (2020) Prognostic value of OCT4 in colorectal cancer: analysis using immunohistochemistry and bioinformatics validation. Biomarkers in Medicine 14:15, pages 1473-1484.
Crossref
Wing Yin Cheng, Chun-Ying Wu & Jun Yu. (2020) The role of gut microbiota in cancer treatment: friend or foe?. Gut 69:10, pages 1867-1876.
Crossref
Mi Ra Yu, Hye Jung Kim, Ji Wan Kang, Yun Hak Kim & Hae Ryoun Park. (2020) Next-generation sequencing analysis of exosomal microRNAs: <i>Fusobacterium</i><i>nucleatum</i> regulates the expression profiling of exosomal microRNAs in human colorectal cancer cells. International Journal of Oral Biology 45:3, pages 134-142.
Crossref
Mi Ra Yu, Hye Jung Kim & Hae Ryoun Park. (2020) Fusobacterium nucleatum Accelerates the Progression of Colitis-Associated Colorectal Cancer by Promoting EMT. Cancers 12:10, pages 2728.
Crossref
Reetu Mukherji & Benjamin A Weinberg. (2020) The gut microbiome and potential implications for early-onset colorectal cancer. Colorectal Cancer 9:3.
Crossref
Natsumi Fujiwara, Naoya Kitamura, Kaya Yoshida, Tetsuya Yamamoto, Kazumi Ozaki & Yasusei Kudo. (2020) Involvement of Fusobacterium Species in Oral Cancer Progression: A Literature Review Including Other Types of Cancer. International Journal of Molecular Sciences 21:17, pages 6207.
Crossref
Stephen H. Kasper, Carolina Morell-Perez, Thomas P. Wyche, Theodore R. Sana, Linda A. Lieberman & Erik C. Hett. (2020) Colorectal cancer-associated anaerobic bacteria proliferate in tumor spheroids and alter the microenvironment. Scientific Reports 10:1.
Crossref
Christian Gethings-Behncke, Helen G. Coleman, Haydee W.T. Jordao, Daniel B. Longley, Nyree Crawford, Liam J. Murray & Andrew T. Kunzmann. (2020) Fusobacterium nucleatum in the Colorectum and Its Association with Cancer Risk and Survival: A Systematic Review and Meta-analysis . Cancer Epidemiology, Biomarkers & Prevention 29:3, pages 539-548.
Crossref
Kun Song, Jingduo Hao, Zuyin Ge & Pushi Chen. (2020) Clinical and Survival Impact of Sex-Determining Region Y-Box 2 in Colorectal Cancer: An Integrated Analysis of the Immunohistochemical Study and Bioinformatics Analysis. Journal of Oncology 2020, pages 1-11.
Crossref
Emilie Palmgren Colov, Thea Helene Degett, Hans Raskov & Ismail Gögenur. (2020) The impact of the gut microbiota on prognosis after surgery for colorectal cancer – a systematic review and meta‐analysis. APMIS 128:2, pages 162-176.
Crossref
Elena Zagato, Chiara Pozzi, Alice Bertocchi, Tiziana Schioppa, Fabiana Saccheri, Silvia Guglietta, Bruno Fosso, Laura Melocchi, Giulia Nizzoli, Jacopo Troisi, Marinella Marzano, Bianca Oresta, Ilaria Spadoni, Koji Atarashi, Sara Carloni, Stefania Arioli, Giulia Fornasa, Francesco Asnicar, Nicola Segata, Simone Guglielmetti, Kenya Honda, Graziano Pesole, William Vermi, Giuseppe Penna & Maria Rescigno. (2020) Endogenous murine microbiota member Faecalibaculum rodentium and its human homologue protect from intestinal tumour growth. Nature Microbiology 5:3, pages 511-524.
Crossref
Li Xiao, Qianyu Zhang, Yanshuang Peng, Daqing Wang & Ying Liu. (2020) The effect of periodontal bacteria infection on incidence and prognosis of cancer. Medicine 99:15, pages e19698.
Crossref
L. Lizha Mary, M. Vasantha Kumar & R. Satish. 2020. Cancer Stem Cells: New Horizons in Cancer Therapies. Cancer Stem Cells: New Horizons in Cancer Therapies 197 221 .
Lelde Lauka, Elisa Reitano, Maria Clotilde Carra, Federica Gaiani, Paschalis Gavriilidis, Francesco Brunetti, Gian Luigi de’Angelis, Iradj Sobhani & Nicola de’Angelis. (2019) Role of the intestinal microbiome in colorectal cancer surgery outcomes. World Journal of Surgical Oncology 17:1.
Crossref
Daniele Vergara, Pasquale Simeone, Marina Damato, Michele Maffia, Paola Lanuti & Marco Trerotola. (2019) The Cancer Microbiota: EMT and Inflammation as Shared Molecular Mechanisms Associated with Plasticity and Progression. Journal of Oncology 2019, pages 1-16.
Crossref
Elena Monica Borroni, Dorina Qehajaj, Floriana Maria Farina, Daniel Yiu, Robert S. Bresalier, Maurizio Chiriva-Internati, Leonardo Mirandola, Sanja Štifter, Luigi Laghi & Fabio Grizzi. (2019) Fusobacterium nucleatum and the Immune System in Colorectal Cancer. Current Colorectal Cancer Reports 15:5, pages 149-156.
Crossref
Yunjia Yang, Minda Zhang, Chenyu Jin, Yang Ding, Mengdi Yang, Rui Wang, Yunjiang Zhou, Yang Zhou, Tao Li, Keke Wang & Rong Hu. (2019) Absent in melanoma 2 suppresses epithelial‐mesenchymal transition via Akt and inflammasome pathways in human colorectal cancer cells. Journal of Cellular Biochemistry 120:10, pages 17744-17756.
Crossref
Qinsong Sheng, Haixia Du, Xiaofei Cheng, Xiaobin Cheng, Yunning Tang, Lelin Pan, Qunmin Wang & Jianjiang Lin. (2019) Characteristics of fecal gut microbiota in patients with colorectal cancer at different stages and different sites. Oncology Letters.
Crossref
Seul A. Lee, Fang Liu, Stephen M. Riordan, Cheok S. Lee & Li Zhang. (2019) Global Investigations of Fusobacterium nucleatum in Human Colorectal Cancer. Frontiers in Oncology 9.
Crossref
Hiroyuki Yamamoto & Kohzoh Imai. (2019) An updated review of microsatellite instability in the era of next-generation sequencing and precision medicine. Seminars in Oncology 46:3, pages 261-270.
Crossref
Nasser Hashemi Goradel, Siamak Heidarzadeh, Samira Jahangiri, Bagher Farhood, Keywan Mortezaee, Neda Khanlarkhani & Babak Negahdari. (2018) Fusobacterium nucleatum and colorectal cancer: A mechanistic overview . Journal of Cellular Physiology 234:3, pages 2337-2344.
Crossref
Yang Liu, Yoshifumi Baba, Takatsugu Ishimoto, Masaaki Iwatsuki, Yukiharu Hiyoshi, Yuji Miyamoto, Naoya Yoshida, Rong Wu & Hideo Baba. (2018) Progress in characterizing the linkage between Fusobacterium nucleatum and gastrointestinal cancer. Journal of Gastroenterology 54:1, pages 33-41.
Crossref
Dervla Kelly, Liying Yang & Zhiheng Pei. (2018) Gut Microbiota, Fusobacteria, and Colorectal Cancer. Diseases 6:4, pages 109.
Crossref
Chaojie Liang, Tuanjie Zhao, Hua Ge, Yingchen Xu, Shulin Ren, Chaosen Yue, Guangming Li & Jixiang Wu. (2018) The clinicopathological and prognostic value of Nanog in human gastrointestinal luminal cancer: A meta-analysis. International Journal of Surgery 53, pages 193-200.
Crossref
Minoru Koi, Yoshiki Okita & John M. Carethers. (2018) <i>Fusobacterium nucleatum</i> Infection in Colorectal Cancer: Linking Inflammation, DNA Mismatch Repair and Genetic and Epigenetic Alterations. Journal of the Anus, Rectum and Colon 2:2, pages 37-46.
Crossref